Welcome to our dedicated page for Roadzen SEC filings (Ticker: RDZN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Roadzen, Inc. filings document an operating insurance technology company incorporated in the British Virgin Islands with Nasdaq-listed ordinary shares and warrants. The company’s 8-K reports disclose material events involving AI insurance agents, underwriting and claims automation, VehicleCare claims-repair activity, presentations on its AI architecture, material agreements, and amendments to junior convertible note financing.
Roadzen’s proxy and shareholder-meeting filings cover board elections, auditor ratification, shareholder voting results, and director changes. Its securities disclosures also identify capital-structure terms, including ordinary shares and warrants exercisable for one ordinary share, alongside governance, financing, business-performance, and risk-related information tied to its AI, insurance, mobility, and repair-network operations.
Roadzen Inc. (Nasdaq: RDZN) has filed a Rule 424(b)(5) prospectus supplement to sell 1,730,769 ordinary shares at a fixed US$1.30, a 15% discount to the 25-Jul-25 close of US$1.53. Gross proceeds are US$2.25 million; after a 6% placement fee payable to Maxim Group (US$135k) and ~US$65k expenses, net proceeds are estimated at US$2.10 million.
The deal is best-efforts with no escrow or minimum; investors could fund the Company even if limited capital is raised. Shares outstanding will rise 2.3% from 74.29 million to 76.02 million. Pro-forma tangible book deficit improves slightly to –US$0.32 per share, but new investors face immediate US$1.62 dilution relative to the as-adjusted book value.
Use of proceeds: working capital and general corporate purposes, with discretion to repay short-term debt (US$11.5 m senior notes, US$2.3 m junior convertibles, US$1.5 m NP1 note, all due FY26). Management retains broad discretion.
Key risks highlighted: substantial doubt about going-concern status due to recurring losses and negative cash flow; potential PFIC classification; absence of dividend; thin trading liquidity; further dilution from 42.2 million potentially issuable shares (warrants, RSUs, etc.). Closing is expected 29-Jul-25.
Roadzen (NASDAQ:RDZN) filed its Annual Report (10-K) for the fiscal year ended 31 Mar 2025 (FY 2024).
The filing outlines a multi-layered capital structure featuring warrants exercisable at $11.50, several convertible debenture series (N1-N4), senior secured notes, and convertible promissory notes. It discloses fair-value measurements for derivative warrant liabilities, forward contracts, and convertible debt across Level 1-3 inputs.
Operational disclosures include two primary revenue categories—Insurance Service and Commission & Distribution Service—plus customer concentration risks tied to Customers One, Two and Three. The report references intangible assets (internal-use software, IP, trademarks) and segment entities such as Global Insurance Management and Moonshot Internet SAS.
Investors should note extensive use of stock-based compensation, multiple warrant classes (public & private), and potential dilution from forward purchase agreements.
Roadzen (NASDAQ: RDZN) filed an 8-K under Item 2.02 to furnish its financial results for the fiscal year ended March 31, 2025. The detailed numbers are contained in the accompanying press release (Exhibit 99.1), which is incorporated by reference but not included in the body of the filing.
The company clarifies the information is furnished, not filed, limiting its liability under Exchange Act Section 18. No forward-looking statements, EPS, revenue, or cash-flow figures are disclosed in the 8-K text itself, so investors must review Exhibit 99.1 for performance metrics and guidance.